Inotuzumab Ozogamicin

62 interactions 4 explained in plain English

Also sold as: Besponsa

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Lefamulin Moxifloxacin Injection Mefloquine Deutetrabenazine Oxaliplatin Injection Olodaterol Oral Inhalation

62 Major

All (62) Major (62)

Major

Inotuzumab Ozogamicin Amitriptyline Elavil Explained Increased risk of QT-interval prolongation Details Inotuzumab Ozogamicin Sertraline Explained An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Inotuzumab Ozogamicin Arsenic Trioxide Trisenox Increased risk of QT-interval prolongation Details Inotuzumab Ozogamicin Aripiprazole Injection Abilify Increased risk of QT-interval prolongation Details Inotuzumab Ozogamicin Arsenic Trioxide Injection Trisenox Increased risk of QT-interval prolongation Details Inotuzumab Ozogamicin Asenapine Transdermal Patch Secuado Increased risk of QT-interval prolongation Details Inotuzumab Ozogamicin Azithromycin AzaSite Increased risk of QT-interval prolongation Details Inotuzumab Ozogamicin Alfuzosin UroXatral Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Anagrelide Agrylin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Bedaquiline Sirturo Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Chloroquine Aralen® Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Dasatinib Phyrago Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Deutetrabenazine Austedo Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Disopyramide Norpace Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Dofetilide Tikosyn Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Dolasetron Anzemet Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Dolasetron Injection Anzemet Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Encorafenib Braftovi Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Eribulin Injection Halaven Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Famotidine Calmicid Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Famotidine Injection Calmicid Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Felbamate Felbatol Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Flecainide Tambocor® Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Foscarnet Injection Foscavir Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Fostemsavir Rukobia Increased risk of torsade de pointes Details Inotuzumab Ozogamicin Galantamine Razadyne Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Gatifloxacin Ophthalmic Zymar® Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Gemifloxacin Factive Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Glasdegib Daurismo Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Granisetron Transdermal Patch Sancuso Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Granisetron Injection Granisol Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Ivabradine Corlanor Increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.